Artigos sendo lidos neste momento !

Autor: admin

Destaques

Novartis to acquire Speedel 

Basel, Switzerland – Novartis has announced that it intends to acquire Speedel, the company that holds the rights to the renin inhibitor aliskiren (Tekturna/Rasilez), which Novartis already markets as an antihypertensive under a license agreement [1]. With the acquisition, Novartis would gain greater flexibility and…

Destaques

CHD patients have poor quality of life 

Atlanta, GA – Coronary heart disease has a significant impact on health-related quality of life, a new study shows [1]. Furthermore, there are big variations in quality of life across different subgroups of people with CHD—for example, by age and by race, say Dr Jipan…